Connection

SRIDEVI DEVARAJ to Monocytes

This is a "connection" page, showing publications SRIDEVI DEVARAJ has written about Monocytes.
Connection Strength

5.568
  1. Monocyte cell adhesion molecule receptors in nascent metabolic syndrome. Clin Biochem. 2016 Apr; 49(6):505-507.
    View in: PubMed
    Score: 0.428
  2. Endosomal Toll-Like Receptor Status in Patients with Metabolic Syndrome. Metab Syndr Relat Disord. 2015 Dec; 13(10):477-80.
    View in: PubMed
    Score: 0.424
  3. Monocytes from metabolic syndrome subjects exhibit a proinflammatory M1 phenotype. Metab Syndr Relat Disord. 2014 Sep; 12(7):362-6.
    View in: PubMed
    Score: 0.384
  4. Increased expression of Fc-? receptors on monocytes in patients with nascent metabolic syndrome. J Clin Endocrinol Metab. 2013 Sep; 98(9):E1510-5.
    View in: PubMed
    Score: 0.363
  5. Circulating versus cellular biomarkers of inflammation in Type 1 diabetes: the superiority of C-reactive protein. Cytokine. 2012 Oct; 60(1):318-20.
    View in: PubMed
    Score: 0.335
  6. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. 2011 May; 22(5):450-8.
    View in: PubMed
    Score: 0.294
  7. Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications. Metabolism. 2011 Feb; 60(2):256-9.
    View in: PubMed
    Score: 0.285
  8. Increased secretion of IP-10 from monocytes under hyperglycemia is via the TLR2 and TLR4 pathway. Cytokine. 2009 Jul; 47(1):6-10.
    View in: PubMed
    Score: 0.271
  9. Validation of the circulating monocyte being representative of the cholesterol-loaded macrophage: biomediator activity. Arch Pathol Lab Med. 2008 Sep; 132(9):1432-5.
    View in: PubMed
    Score: 0.258
  10. CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions. Am J Physiol Heart Circ Physiol. 2006 Sep; 291(3):H1170-6.
    View in: PubMed
    Score: 0.218
  11. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006 Mar; 55(3):774-9.
    View in: PubMed
    Score: 0.217
  12. Alpha-tocopherol decreases tumor necrosis factor-alpha mRNA and protein from activated human monocytes by inhibition of 5-lipoxygenase. Free Radic Biol Med. 2005 May 01; 38(9):1212-20.
    View in: PubMed
    Score: 0.205
  13. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes. 2005 Jan; 54(1):85-91.
    View in: PubMed
    Score: 0.200
  14. Modulation of monocyte-macrophage function with alpha-tocopherol: implications for atherosclerosis. Nutr Rev. 2002 Jan; 60(1):8-14.
    View in: PubMed
    Score: 0.163
  15. lncRNA DRAIR is downregulated in diabetic monocytes and modulates the inflammatory phenotype via epigenetic mechanisms. JCI Insight. 2021 06 08; 6(11).
    View in: PubMed
    Score: 0.156
  16. Factors that promote macrophage homing to adipose tissue in metabolic syndrome. J Diabetes Complications. 2016 Nov - Dec; 30(8):1434-1436.
    View in: PubMed
    Score: 0.112
  17. (-)-Epicatechin attenuates high-glucose-induced inflammation by epigenetic modulation in human monocytes. Eur J Nutr. 2017 Apr; 56(3):1369-1373.
    View in: PubMed
    Score: 0.107
  18. Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. Diabetes. 2014 Dec; 63(12):4249-61.
    View in: PubMed
    Score: 0.097
  19. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. J Clin Endocrinol Metab. 2012 Oct; 97(10):E1844-50.
    View in: PubMed
    Score: 0.085
  20. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012 Apr; 35(4):900-4.
    View in: PubMed
    Score: 0.082
  21. Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem. 2012 Jul; 23(7):699-705.
    View in: PubMed
    Score: 0.079
  22. C-reactive protein polarizes human macrophages to an M1 phenotype and inhibits transformation to the M2 phenotype. Arterioscler Thromb Vasc Biol. 2011 Jun; 31(6):1397-402.
    View in: PubMed
    Score: 0.077
  23. Low vitamin D levels correlate with the proinflammatory state in type 1 diabetic subjects with and without microvascular complications. Am J Clin Pathol. 2011 Mar; 135(3):429-33.
    View in: PubMed
    Score: 0.077
  24. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2011 Jan; 31(1):160-6.
    View in: PubMed
    Score: 0.075
  25. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology. 2009 Aug; 150(8):3457-64.
    View in: PubMed
    Score: 0.067
  26. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Clin Chem. 2009 Feb; 55(2):361-4.
    View in: PubMed
    Score: 0.066
  27. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008 Nov; 57(11):3090-8.
    View in: PubMed
    Score: 0.064
  28. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes. 2007 Nov; 56(11):2790-6.
    View in: PubMed
    Score: 0.060
  29. Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes. J Clin Endocrinol Metab. 2007 Aug; 92(8):3136-40.
    View in: PubMed
    Score: 0.059
  30. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab. 2007 Jul; 293(1):E337-46.
    View in: PubMed
    Score: 0.059
  31. Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome. J Clin Endocrinol Metab. 2006 Nov; 91(11):4489-96.
    View in: PubMed
    Score: 0.056
  32. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes. 2002 Oct; 51(10):3049-54.
    View in: PubMed
    Score: 0.043
  33. Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis. Am J Physiol Endocrinol Metab. 2019 03 01; 316(3):E504-E509.
    View in: PubMed
    Score: 0.033
  34. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010 Apr; 33(4):861-8.
    View in: PubMed
    Score: 0.018
  35. Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. Am J Cardiol. 2008 Aug 01; 102(3):321-5.
    View in: PubMed
    Score: 0.016
  36. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 May 02; 113(17):2135-50; discussion 2150.
    View in: PubMed
    Score: 0.014
  37. Supplementation with omega3 polyunsaturated fatty acids and all-rac alpha-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism. 2004 Feb; 53(2):236-40.
    View in: PubMed
    Score: 0.012
  38. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002 Sep 17; 106(12):1439-41.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.